• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » LabConnect Hires Former Quintiles Exec to be COO

LabConnect Hires Former Quintiles Exec to be COO

August 28, 2009
CenterWatch Staff

LabConnect, a provider of central laboratory services to the clinical trial industry, appointed former Quintiles executive Frank Morrow, Ph.D., as its chief operating officer.

Morrow was founding executive, president and chief scientific officer at Quintiles Laboratories Worldwide before joining LabConnect. According to LabConnect, he was responsible for growing Quintiles’ lab from inception to $120 million in revenue, 1,000 employees and five worldwide central lab facilities.

Elsewhere in the clinical trial industry, ICON named Alan Marion, M.D., Ph.D., vice president and medical director of the contract research organization’s (CRO’s) new clinical pharmacology unit in Omaha, Neb. Prior to joining ICON, Marion was principal investigator at MDS Pharma Services.

CRO Health Decisions hired Craig Hurt as its new controller to “prime” the company for growth, according to Health Decisions’ chief financial officer, Alicia Paladin. Hurt, a licensed CPA, will manage all accounting and finance functions, including compliance with GAAP and regulatory authorities, for the CRO. He was formerly senior finance manager at Nortel.

Former INC Research and PPD executive Becky Causey has been named executive vice president of clinical operations for ResearchPoint. In this role, Causey will assist in defining processes and strategic direction for operations for the CRO.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing